Tg Therapeutics (TGTX) Other Operating Expenses (2016 - 2025)
Historic Other Operating Expenses for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to $28.1 million.
- Tg Therapeutics' Other Operating Expenses rose 20074.94% to $28.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.0 million, marking a year-over-year increase of 15200.71%. This contributed to the annual value of $38.5 million for FY2024, which is 17235.16% up from last year.
- Per Tg Therapeutics' latest filing, its Other Operating Expenses stood at $28.1 million for Q3 2025, which was up 20074.94% from $18.9 million recorded in Q2 2025.
- In the past 5 years, Tg Therapeutics' Other Operating Expenses registered a high of $28.1 million during Q3 2025, and its lowest value of $2000.0 during Q3 2022.
- Moreover, its 5-year median value for Other Operating Expenses was $1.9 million (2023), whereas its average is $6.1 million.
- Per our database at Business Quant, Tg Therapeutics' Other Operating Expenses tumbled by 9931.51% in 2022 and then soared by 26170000.0% in 2023.
- Quarter analysis of 5 years shows Tg Therapeutics' Other Operating Expenses stood at $210000.0 in 2021, then plummeted by 98.57% to $3000.0 in 2022, then soared by 261700.0% to $7.9 million in 2023, then skyrocketed by 96.07% to $15.4 million in 2024, then skyrocketed by 82.43% to $28.1 million in 2025.
- Its Other Operating Expenses stands at $28.1 million for Q3 2025, versus $18.9 million for Q2 2025 and $15.5 million for Q1 2025.